Azulfidine EN-tabs 500 mg/1 (Sulfasalazine TABLET, DELAYED RELEASE) 500 mg/1

Azulfidine EN-tabs 500 mg is a delayed-release tablet used for managing inflammatory conditions. This medication combines sulfasalazine for effective symptom relief.

Strength

500 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0013-0102-60) / 300 TABLET, DELAYED RELEASE in 1 BOTTLE

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Azulfidine EN-tabs 500 mg is commonly used to manage inflammatory conditions such as rheumatoid arthritis and ulcerative colitis. It works by reducing inflammation in the body, providing relief from symptoms like joint pain and swelling. People often ask, 'What is Azulfidine used for?' and the answer includes managing chronic inflammatory disorders.

Side Effects

Common effects of Azulfidine EN-tabs 500 mg may include nausea, vomiting, and headache. Some users also report mild stomach discomfort. These effects vary and are not experienced by everyone.

Precautions & Warnings

Azulfidine EN-tabs 500 mg should be handled with care. It is important to follow the guidance of a healthcare provider, especially regarding potential allergies or pre-existing conditions. Always store the medication in a cool, dry place.

Avoid Interactions

Azulfidine EN-tabs 500 mg may interact with certain medications, including other anti-inflammatory drugs and blood thinners. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

Azulfidine EN-tabs 500 mg is used to manage inflammatory conditions like rheumatoid arthritis and ulcerative colitis.

Azulfidine EN-tabs 500 mg should be taken orally, typically with a full glass of water, unless otherwise directed by a healthcare provider.

Common side effects may include nausea, vomiting, and headache. These effects vary among individuals.

Azulfidine EN-tabs 500 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Azulfidine EN-tabs 500 mg should be stored in a cool, dry place, away from direct sunlight and moisture.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.